Structure/Function Relationships in the Inhibition of Thimet Oligopcpti,Tase by Carboxyphenyl Propyl-Peptides

Total Page:16

File Type:pdf, Size:1020Kb

Structure/Function Relationships in the Inhibition of Thimet Oligopcpti,Tase by Carboxyphenyl Propyl-Peptides Volume 294. number 3. 183-186 FEBS 10458 Dc~:cmlx-r IO91 ~ 1991 Federation of European Biochemical Societies 00145793/91/$3._~t) Structure/function relationships in the inhibition of thimet oligopcpti,tase by carboxyphenyl propyl-peptides C. Graham Knight and Alan J. Barrett Der~rcs~ncnl of Bi¢~chemistrt'. Strangeway$ Research Laboratory. EVorts Causeway. Cambridge CBI 4RN. UN Received 26 September I(~I; revised version received 17 October 1991 Some novel N-[l(RS)-carboxy-3-phenylpropyl]trilaeptide p-aminobcnzoates hawe bexm synthesised as inhibitors of lhimet oligopeptidas¢ (EC 3.4.24.151. The~e compounds are considered to bind as substrate analogues with the Cpp group in SI and the l~ptide portion in the S" ~ite~. The most Dotc,t inhibitor is Cpp-Ala-Pro-Phe-pAb. which has a K. - 7 nM. Substitution of (~ly for Ala at Pl" leads to weaker binding which can be ascribed to increa.~d rotational tr~x'dom. Good substrates often have Pro at P2" and Pro is favoured over Ala at this position in the inhihitors, too. When P2" is Pro. Phe is preferr~ over Tyr and Tip in P3 +. The p-amlnobenToate group makes an ;ml~,rtant contribution to the binding, probably by forming a .salt bridge, and removal of the ('-terminal negative 4zhargc results in much less potcnl inhibitors. EC 3.4.24. I S; Fm, ym© inhibition; Subsite specificity i. INTRODUCTION tide-pAb are competitive inhibitors, and since the most potent have peptide structures analogous to those of Thimet oligopeptidase (EC 3.4.24.15) is ~" thiol-de- good substrates [4], the amino acid sidechains pre- pendent metallo-endopeptidase widely distributed in sumably occupy the same specificity subsites on the dells and tissues, and previously known by the names enzyme. By convention [7], these subsites are labelled S Pz-peptidase, endo-oligopeptidase A and soluble endo- to the N-terminal side of the scissile bond and S" to the peptidase 24.15 [I]. Characteristic features of the en- C-terminal side, numbering being away from the bond zyme are the inhibition by both chelators and thiol- cleaved, the scissile bond. The amino acid residues reactive reagents and activation by low concentrations which occupy these subsites are labelled P and P', re- of thiols. The biological function of thimct oligo- spectively. Although it is not yet possible to define the peptidase is unknown, but is capable in vitro of generat- characteristics of the subsites precisely [I], good sub- ing or destroying a number of pharmacologically active strates and inhibitors of thimet oligopeptidase com- peptides and is found in the highest concentrations in monly have hydrophobic residues at Pi and PY [2,4]. the soluble protein fraction of testis, brain and pituitary In addition to their use in biological experiments, [2]. lnhibitors may provide the best approach to inves- inhibitors more potent than those currently available tigating the physiological role of the enzyme [3]. are needed for active site titration of the enzyme, so that Thimet oligopeptidase is selectively and reversibly in- kinetic studies can be placed on a quantitative basis. hibited by N-[l(RS)-carboxy-3-phenylpropyi]tripeptide Also needed are inhibitors more resistant to degrada- p-aminobenzoates (Cpp-peptide-pAb) [4,5]. The mecha- tion, which currently complicates their use in studies of nism of inhibition may be similar to that proposed for the role of thimet oligopeptidase in vivo [3]. We now thermolysin and Cpp-Leu-Trp [6], where X-ray crystal- report our initial studies to investigate the relationships lography has revealed the coordination of the carboxyl between inhibitor structure and function. ol the Cpp group to the Zn atom in the active site of the enzyme. In thimet oligopeptidase, interaction of the 3- 2. EXPERIMENTAL phenyl ring with the hydrophobic S I subsite also makes 2.]. Maaet4ais an important contribution to the binding [4] Cpp-pep- Boc-amino acid N-hydroxysuc~nimide esters, p-aminobenzoic acid and L-phenylalanine derivatives ~ from Sigma. Uoc-amino acid Abbrevlatlons: Ahx, L-2-aminohexanoic acid; Boc, t-butyloxycarbo- p.aminobenzoates were made as de~ribed [8]. Ethyl; 2-keto-4-phenyl- ttyl; CI~, N-[It(RSk-¢arboxy-3-phenylpropyli; Drip, dinitrophenyl; butanoat© from Scbeizerhall (South Plainfield, NJ 07080) was saponi- Moc. 7-melhoxyooumarin-3<arboxylyl; ONSu, N-hydroxystt~ni- fled with NaOH to yield the sodium salt. Cpl~Ala-Ala-Tyr-pAb was mide ester; pAb. p-aminobenzoat¢; Pz. phenylaz.obertzyloxycarbonyl. a gift from Dr. M. Orlowski. Mount Sinai School of Medicine, New York, USA. Moc-Pro-I..eu-Oly-Pro-D-Lys(Dnp) was made by solid Corresptmdence address: C.O. Knight, Departmem of Bk~hcmistry, phase pepcide ~tnthe~ 19L Rat t,n~t~ mim~ ~ w.as puri- Strangeways Research Laboratory, Worts Causeway, Cambridge fied by a method similar to that used for the chicken enzyn~ 15|. and CBI 4RN, UK. ga~e a single band of "/6 kDa in SDS?l~amli~ ~ doctralphorcsh. Pub/is&ed by E./sev~r Sck,nce Pub/t~'rs B. g,'. 183 Votume .~4. number 3 UEBS LETTERS December 1991 2.2. 5;Ynth,'s:.~ ¢,I Cpp-.4la-Pro-Ph*'-p.4~ was controlled, and data colh_.cted and analys~d, hy use of the This was made step-wire by standard ~ltstion-pha~ mctht~cls [4. I0]. VI.USYS software Dackag~ [I I ]. Whe en,wm¢ was pro-activated with Reactions ~crt" ft~llowt~J by HP[.C on a C1~4 L'olumn, clulcd with tt S mM dithiothreitol in assay buffer (50 mM Tris-HCI, DH 7.g, contain- gradient of 5 100~4;, aL~tomtrilc containing 0 I¢IF trIfluorowuctlc acid Ing tlOSqF Itr U iS) for 5 rain at 21"( and then diluted IO*fold and kept (Iml,min) over 25 rain. Tht, colulnn ¢Itiant ~Jas monitored at ".10 rim. at 0"('. A~ay~, were made with OR nM em, yme. based on protein I~--Phe-p,Ab 1384 rag. I retool) gas treatL,~J with trifluolat~llccYic ;lt:iti/ concentration. For the determination of K,. the rate of substrat¢ hy- water I 19 I. ~'~'v. :q) ml) for 20 n~it~ at 21 ~'C to remove the B¢~.- group droly~i~ in the absem.'¢ of inhibitor was first recorded, and then the The acid was removed at 44)°(" in vacuo and the t~sidue was dissolved inhibitor was add~ in a negligible volume and the new steady stale in dimcthylfomlamidc (Sail, To this ,~tuiion was addc~l B~'-Pro- was monitored Rapid equilibration was observed in all cases. Ap- ONSu (330 rag, I I mmolL l-hydroxyl~n~otria~c~le (I 35 g, I ntm~i) parent inhibition constants A'.=r~., were calculated by fitting Ihe frac- and di-isopropylethylamine (O.7 ml. 4 mmolL After stirring overnight, tional activity darn to II1¢ Mlorrisort L~quation [I 2| by nonlin~r relgl~o analysis by HPLC sho~k~t."d the reaction to the complete. The dimethyl- sion, using the p¢ogt am En~litter ! I-Ascvier-Biosofl, Cambridge, UK). formam/d~ was evaporated at 40°(" in vacuo and chloroform (~) ml) Values wct'¢ corrected lor the effoet ofsubstrate by using equation (t). was adld~. After eglra~liom with ~ tw/v} citric acid (2 ~< ~ mlL water 120 ml) and saturaled Na('l (20 roll the chloroform solution was K, = K.~.~/(I ÷ [SFK.) (l) dried (M8SO4) and evaporated to leave crude Boc-Pro-Phe-pAh_ This was Ptx-rystalli~L'd from ethi*nol/water (yielding 0.46 g. 95~[-I and A value of 16 .u M was dctcrmin*~! for Km. The different:c~ in K, va|tt~ treated with tri~luoroa,cctic acid/water as described above, The residue I'~twL~n hthibitors were converted into differences in the fr~ energy after evaporation was dissolved in dimethylformamkle and reacted of binding t~(~. d hy equation (2), with Eloc.Ala.~)NS¢ (2~ mr. I mmoh. I-hydroxybenzotriazote and di-isop~xspylethylamine. As before, the solvent was evaporated after --. -2.303RT- Iogl reac*ion overnight and the residue dissolved in chloroform, extracted 66G~,.a K,,tK',:) (2) and dried. The crude Ek~-Ala-Pro-Phe-pAb was 97q~, pure by HPL(" analysis and was treated with trifluoroa~i~tic acid without further purification. The residue after evaporation was dissolved in methanol/ 3. RESULTS AND DISCUSSION water ( 1:1 v/v, ~ ml) and brought to pH 7 with 5 M NaOH. Sodium 3. I. A lanine is fitvoured in Pl" 3-phcnyl-2-ketobutyrate ( I g, 5 retool) and sodium cyanoborohydride (0.32 g. 5 retool) were added and She mixture stirr~ at 2 I~'C. HPLC Good peptide substrates of thimct oligopeptidase analysis showed that reaction was ~.~.~mplete after 24 h. The solveats commonly have hydrophobic residuesin PI and P3". and were evaporated, water (50 ml) was added and the ,solution acidified arginine is often found in Pl" [2], suggesting that the SI" with 6 M HCI ( 1.5 ml) to precipitate Cpp-Ala-Pro-Phe-pAb.HCI. The site of the enzyme is accessible to large side chains. This crude prodtu:t wa,~ washed with ethyl acetate, and reerystallised from ethanol and water, yielding 0.33g ¢49~-), m,p. IS? 188°C. Analysis: conclusion is supported by studies with inhibitors, since calculated for C,,H~N~O~.H(?I (M, 679.2) C. 62.72; H, 6.O4; N. 8.60; the K, of Cpp-Ph¢-Ala-Phe-pAb is only 3-fold that of t~)und (', 62.98: H, 6.1 I; N. 8.60. Cpp-Ala-Phe-pAb [4] (Table 1). Leucine. however, is The other inhibitors w~re mad~ by similar methods.
Recommended publications
  • Mediate Immune Evasion Aureolysin Cleaves Complement C3 To
    Staphylococcus aureus Metalloprotease Aureolysin Cleaves Complement C3 To Mediate Immune Evasion This information is current as Alexander J. Laarman, Maartje Ruyken, Cheryl L. Malone, of September 29, 2021. Jos A. G. van Strijp, Alexander R. Horswill and Suzan H. M. Rooijakkers J Immunol 2011; 186:6445-6453; Prepublished online 18 April 2011; doi: 10.4049/jimmunol.1002948 Downloaded from http://www.jimmunol.org/content/186/11/6445 Supplementary http://www.jimmunol.org/content/suppl/2011/04/18/jimmunol.100294 Material 8.DC1 http://www.jimmunol.org/ References This article cites 56 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/186/11/6445.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 29, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Staphylococcus aureus Metalloprotease Aureolysin Cleaves Complement C3 To Mediate Immune Evasion Alexander J.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • R&D Assay for Alzheimer's Disease
    R&DR&D assayassay forfor Alzheimer’sAlzheimer’s diseasedisease Target screening⳼ Ⲽ㬔 antibody array, ᢜ⭉㬔 ⸽ἐⴐ Amyloid β-peptide Alzheimer’s disease⯸ ኸᷠ᧔ ᆹ⸽ inhibitor, antibody, ELISA kit Surwhrph#Surilohu#Dqwlerg|#Duud| 6OUSFBUFE 1."5SFBUFE )41 $3&# &3, &3, )41 $3&# &3, &3, 壤伡庰䋸TBNQMF ɅH 侴䋸嵄䍴䋸BOBMZUFT䋸䬱娴哜塵 1$ 1$ 1$ 1$ 5IFNPTUSFGFSFODFEBSSBZT 1$ 1$ QQ α 34, .4, 503 Q α 34, .4, 503 %SVHTDSFFOJOH0òUBSHFUFòFDUT0ATHWAY涭廐 6OUSFBUFE 堄币䋸4BNQMF侴䋸8FTUFSOPS&-*4"䍘䧽 1."5SFBUFE P 8FTUFSOCMPU廽喜儤应侴䋸0, Z 4VCTUSBUF -JHIU )31DPOKVHBUFE1BO "OUJQIPTQIPUZSPTJOF .FBO1JYFM%FOTJUZ Y $BQUVSF"OUJCPEZ 5BSHFU"OBMZUF "SSBZ.FNCSBOF $3&# &3, &3, )41 .4, Q α 34, 503 Human XL Cytokine Array kit (ARY022, 102 analytes) Adiponectin,Aggrecan,Angiogenin,Angiopoietin-1,Angiopoietin-2,BAFF,BDNF,Complement,Component C5/C5a,CD14,CD30,CD40L, Chitinase 3-like 1,Complement Factor D,C-Reactive Protein,Cripto-1,Cystatin C,Dkk-1,DPPIV,EGF,EMMPRIN,ENA-78,Endoglin, Fas L,FGF basic,FGF- 7,FGF-19,Flt-3 L,G-CSF,GDF-15,GM-CSF,GRO-α,Grow th Hormone,HGF,ICAM-1,IFN-γ,IGFBP-2,IGFBP-3, IL-1α,IL-1β, IL-1ra,IL-2,IL-3,IL-4,IL- 5,IL-6,IL-8, IL-10,IL-11,IL-12, IL-13,IL-15,IL-16,IL-17A,IL-18 BPa,IL-19,IL-22, IL-23,IL-24,IL-27, IL-31,IL-32α/β/γ,IL-33,IL-34,IP-10,I-TAC,Kallikrein 3,Leptin,LIF,Lipocalin-2,MCP-1,MCP-3,M-CSF,MIF,MIG,MIP-1α/MIP-1β,MIP-3α,MIP-3β,MMP-9, Myeloperoxidase,Osteopontin, p70, PDGF-AA, PDGF-AB/BB,Pentraxin-3, PF4, RAGE, RANTES,RBP4,Relaxin-2, Resistin,SDF-1α,Serpin E1, SHBG, ST2, TARC,TFF3,TfR,TGF- ,Thrombospondin-1,TNF-α, uPAR, VEGF, Vitamin D BP Human Protease (34 analytes) /
    [Show full text]
  • Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus Faecalis Biofilm Formation
    Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus faecalis Biofilm Formation The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Carniol, K., and M. S. Gilmore. 2004. Signal Transduction, Quorum- Sensing, and Extracellular Protease Activity in Enterococcus Faecalis Biofilm Formation. Journal of Bacteriology 186, no. 24: 8161–8163. doi:10.1128/jb.186.24.8161-8163.2004. Published Version doi:10.1128/JB.186.24.8161-8163.2004 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:33867369 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA JOURNAL OF BACTERIOLOGY, Dec. 2004, p. 8161–8163 Vol. 186, No. 24 0021-9193/04/$08.00ϩ0 DOI: 10.1128/JB.186.24.8161–8163.2004 Copyright © 2004, American Society for Microbiology. All Rights Reserved. GUEST COMMENTARY Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus faecalis Biofilm Formation Karen Carniol1,2 and Michael S. Gilmore1,2* Department of Ophthalmology, Harvard Medical School,1 and The Schepens Eye Research Institute,2 Boston, Massachusetts Biofilms are surface-attached communities of bacteria, en- sponse regulator proteins (10). Only one of the mutants gen- cased in an extracellular matrix of secreted proteins, carbohy- erated, fsrA, impaired the ability of E. faecalis strain V583A to drates, and/or DNA, that assume phenotypes distinct from form biofilms in vitro.
    [Show full text]
  • Proteolytic Enzymes in Grass Pollen and Their Relationship to Allergenic Proteins
    Proteolytic Enzymes in Grass Pollen and their Relationship to Allergenic Proteins By Rohit G. Saldanha A thesis submitted in fulfilment of the requirements for the degree of Masters by Research Faculty of Medicine The University of New South Wales March 2005 TABLE OF CONTENTS TABLE OF CONTENTS 1 LIST OF FIGURES 6 LIST OF TABLES 8 LIST OF TABLES 8 ABBREVIATIONS 8 ACKNOWLEDGEMENTS 11 PUBLISHED WORK FROM THIS THESIS 12 ABSTRACT 13 1. ASTHMA AND SENSITISATION IN ALLERGIC DISEASES 14 1.1 Defining Asthma and its Clinical Presentation 14 1.2 Inflammatory Responses in Asthma 15 1.2.1 The Early Phase Response 15 1.2.2 The Late Phase Reaction 16 1.3 Effects of Airway Inflammation 16 1.3.1 Respiratory Epithelium 16 1.3.2 Airway Remodelling 17 1.4 Classification of Asthma 18 1.4.1 Extrinsic Asthma 19 1.4.2 Intrinsic Asthma 19 1.5 Prevalence of Asthma 20 1.6 Immunological Sensitisation 22 1.7 Antigen Presentation and development of T cell Responses. 22 1.8 Factors Influencing T cell Activation Responses 25 1.8.1 Co-Stimulatory Interactions 25 1.8.2 Cognate Cellular Interactions 26 1.8.3 Soluble Pro-inflammatory Factors 26 1.9 Intracellular Signalling Mechanisms Regulating T cell Differentiation 30 2 POLLEN ALLERGENS AND THEIR RELATIONSHIP TO PROTEOLYTIC ENZYMES 33 1 2.1 The Role of Pollen Allergens in Asthma 33 2.2 Environmental Factors influencing Pollen Exposure 33 2.3 Classification of Pollen Sources 35 2.3.1 Taxonomy of Pollen Sources 35 2.3.2 Cross-Reactivity between different Pollen Allergens 40 2.4 Classification of Pollen Allergens 41 2.4.1
    [Show full text]
  • Structure of Neurolysin Reveals a Deep Channel That Limits Substrate Access
    Structure of neurolysin reveals a deep channel that limits substrate access C. Kent Brown*†, Kevin Madauss*, Wei Lian‡, Moriah R. Beck§, W. David Tolbert¶, and David W. Rodgersʈ Department of Molecular and Cellular Biochemistry and Center for Structural Biology, University of Kentucky, Lexington, KY 40536 Communicated by Stephen C. Harrison, Harvard University, Cambridge, MA, December 29, 2000 (received for review November 14, 2000) The zinc metallopeptidase neurolysin is shown by x-ray crystallog- cytosolic, but it also can be secreted or associated with the raphy to have large structural elements erected over the active site plasma membrane (11), and some of the enzyme is made with a region that allow substrate access only through a deep narrow mitochondrial targeting sequence by initiation at an alternative channel. This architecture accounts for specialization of this neu- transcription start site (12). ropeptidase to small bioactive peptide substrates without bulky Although neurolysin cleaves a number of neuropeptides in secondary and tertiary structures. In addition, modeling studies vitro, its most established (5, 13, 14) role in vivo (along with indicate that the length of a substrate N-terminal to the site of thimet oligopeptidase) is in metabolism of neurotensin, a 13- hydrolysis is restricted to approximately 10 residues by the limited residue neuropeptide. It hydrolyzes this peptide between resi- size of the active site cavity. Some structural elements of neuro- dues 10 and 11, creating shorter fragments that are believed to ␤ lysin, including a five-stranded -sheet and the two active site be inactive. helices, are conserved with other metallopeptidases. The connect- Neurotensin (pGlu-Leu-Tyr-Gln-Asn-Lys-Pro-Arg-Arg- ing loop regions of these elements, however, are much extended Pro s Tyr-Ile-Leu) is found in a variety of peripheral and in neurolysin, and they, together with other open coil elements, central tissues where it is involved in a number of effects, line the active site cavity.
    [Show full text]
  • Functional and Structural Insights Into Astacin Metallopeptidases
    Biol. Chem., Vol. 393, pp. 1027–1041, October 2012 • Copyright © by Walter de Gruyter • Berlin • Boston. DOI 10.1515/hsz-2012-0149 Review Functional and structural insights into astacin metallopeptidases F. Xavier Gomis-R ü th 1, *, Sergio Trillo-Muyo 1 Keywords: bone morphogenetic protein; catalytic domain; and Walter St ö cker 2, * meprin; metzincin; tolloid; zinc metallopeptidase. 1 Proteolysis Lab , Molecular Biology Institute of Barcelona, CSIC, Barcelona Science Park, Helix Building, c/Baldiri Reixac, 15-21, E-08028 Barcelona , Spain Introduction: a short historical background 2 Institute of Zoology , Cell and Matrix Biology, Johannes Gutenberg University, Johannes-von-M ü ller-Weg 6, The fi rst report on the digestive protease astacin from the D-55128 Mainz , Germany European freshwater crayfi sh, Astacus astacus L. – then termed ‘ crayfi sh small-molecule protease ’ or ‘ Astacus pro- * Corresponding authors tease ’ – dates back to the late 1960s (Sonneborn et al. , 1969 ). e-mail: [email protected]; [email protected] Protein sequencing by Zwilling and co-workers in the 1980s did not reveal homology to any other protein (Titani et al. , Abstract 1987 ). Shortly after, the enzyme was identifi ed as a zinc met- allopeptidase (St ö cker et al., 1988 ), and other family mem- The astacins are a family of multi-domain metallopepti- bers emerged. The fi rst of these was bone morphogenetic β dases with manifold functions in metabolism. They are protein 1 (BMP1), a protease co-purifi ed with TGF -like either secreted or membrane-anchored and are regulated growth factors termed bone morphogenetic proteins due by being synthesized as inactive zymogens and also by co- to their capacity to induce ectopic bone formation in mice localizing protein inhibitors.
    [Show full text]
  • Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
    Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48
    [Show full text]
  • Proteolytic Cleavage—Mechanisms, Function
    Review Cite This: Chem. Rev. 2018, 118, 1137−1168 pubs.acs.org/CR Proteolytic CleavageMechanisms, Function, and “Omic” Approaches for a Near-Ubiquitous Posttranslational Modification Theo Klein,†,⊥ Ulrich Eckhard,†,§ Antoine Dufour,†,¶ Nestor Solis,† and Christopher M. Overall*,†,‡ † ‡ Life Sciences Institute, Department of Oral Biological and Medical Sciences, and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada ABSTRACT: Proteases enzymatically hydrolyze peptide bonds in substrate proteins, resulting in a widespread, irreversible posttranslational modification of the protein’s structure and biological function. Often regarded as a mere degradative mechanism in destruction of proteins or turnover in maintaining physiological homeostasis, recent research in the field of degradomics has led to the recognition of two main yet unexpected concepts. First, that targeted, limited proteolytic cleavage events by a wide repertoire of proteases are pivotal regulators of most, if not all, physiological and pathological processes. Second, an unexpected in vivo abundance of stable cleaved proteins revealed pervasive, functionally relevant protein processing in normal and diseased tissuefrom 40 to 70% of proteins also occur in vivo as distinct stable proteoforms with undocumented N- or C- termini, meaning these proteoforms are stable functional cleavage products, most with unknown functional implications. In this Review, we discuss the structural biology aspects and mechanisms
    [Show full text]
  • Thermolysin Product Information #9PIV400
    Certificate of Analysis Thermolysin: Part No. Size Part# 9PIV400 V400A 25mg Revised 1/18 Description: Thermolysin is a thermostable metalloproteinase. The high digestion temperatures may be used as an alternative to denaturants to improve digestion of proteolytically resistant proteins. Thermolysin preferentially cleaves at the N-terminus of the hydrophobic residues leucine, phenylalanine, valine, isoleucine, alanine and methionine. This enzyme can be used alone or in combination with other proteases for protein analysis by mass spectrometry, protein structural studies and other applications. Biological Source: Geobacillus stearothermophilus. Molecular Weight: 36.2kDa (1). Form: Lyophilized. *AF9PIV400 0118V400* Storage Conditions: See the Product Information Label for storage conditions and expiration date. AF9PIV400 0118V400 Optimal pH: 8.0. Thermolysin is stable from pH 5.0–8.5 (2). Activators: Calcium and zinc act as cofactors (3–6). Usage Notes: 1. Resuspend Thermolysin in thermolysin digestion buffer (50mM Tris [pH 8.0], 0.5mM CaCl2). Enzyme is soluble up to 1mg/ml in thermolysin digestion buffer. Store reconstituted Thermolysin at –20°C for up to 2 weeks. 2. The optimal digestion temperature range is 65–85°C. Promega Corporation 2800 Woods Hollow Road Madison, WI 53711-5399 USA Telephone 608-274-4330 Toll Free 800-356-9526 Fax 608-277-2516 Internet www.promega.com Usage Information on Back PRODUCT USE LIMITATIONS, WARRANTY, DISCLAIMER Promega manufactures products for a number of intended uses. Please refer to the product label for the intended use statements for specific products. Promega products contain chemicals which may be harmful if misused. Due care should be exercised with all Promega products to prevent direct human contact.
    [Show full text]
  • Substrate Specificity of Mitochondrial Intermediate Peptidase Analysed By
    FEBS Open Bio 5 (2015) 429–436 journal homepage: www.elsevier.com/locate/febsopenbio Substrate specificity of mitochondrial intermediate peptidase analysed by a support-bound peptide library ⇑ ⇑ M.F.M. Marcondes, F.M. Alves, D.M. Assis 1, I.Y. Hirata, L. Juliano, V. Oliveira , M.A. Juliano Department of Biophysics, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Pedro de Toledo, 669 – 7° andar, São Paulo, Brazil article info abstract Article history: The substrate specificity of recombinant human mitochondrial intermediate peptidase (hMIP) using Received 24 February 2015 a synthetic support-bound FRET peptide library is presented. The collected fluorescent beads, which Revised 20 April 2015 contained the hydrolysed peptides generated by hMIP, were sequenced by Edman degradation. The Accepted 7 May 2015 results showed that this peptidase presents a remarkable preference for polar uncharged residues at 0 0 P1 and P1 substrate positions: Ser = Gln > Thr at P1 and Ser > Thr at P1 . Non-polar residues were fre- 0 0 quent at the substrate P3,P2,P2 and P3 positions. Analysis of the predicted MIP processing sites in imported mitochondrial matrix proteins shows these cleavages indeed occur between polar Keywords: uncharged residues. Previous analysis of these processing sites indicated the importance of posi- oct1 Octapeptidyl amino peptidase 1 tions far from the MIP cleavage site, namely the presence of a hydrophobic residue (Phe or Leu) Peptidase at P8 and a polar uncharged residue (Ser or Thr) at P5. To evaluate this, additional kinetic analyses Mitochondria were carried out, using fluorogenic substrates synthesized based on the processing sites attributed 0 FRET libraries to MIP.
    [Show full text]
  • Biochemical Characterization and Zinc Binding Group (Zbgs) Inhibition Studies on the Catalytic Domains of Mmp7 (Cdmmp7) and Mmp16 (Cdmmp16)
    MIAMI UNIVERSITY The Graduate School Certificate for Approving the Dissertation We hereby approve the Dissertation of Fan Meng Candidate for the Degree DOCTOR OF PHILOSOPHY ______________________________________ Director Dr. Michael W. Crowder ______________________________________ Dr. David L. Tierney ______________________________________ Dr. Carole Dabney-Smith ______________________________________ Dr. Christopher A. Makaroff ______________________________________ Graduate School Representative Dr. Hai-Fei Shi ABSTRACT BIOCHEMICAL CHARACTERIZATION AND ZINC BINDING GROUP (ZBGS) INHIBITION STUDIES ON THE CATALYTIC DOMAINS OF MMP7 (CDMMP7) AND MMP16 (CDMMP16) by Fan Meng Matrix metalloproteinase 7 (MMP7/matrilysin-1) and membrane type matrix metalloproteinase 16 (MMP16/MT3-MMP) have been implicated in the progression of pathological events, such as cancer and inflammatory diseases; therefore, these two MMPs are considered as viable drug targets. In this work, we (a) provide a review of the role(s) of MMPs in biology and of the previous efforts to target MMPs as therapeutics (Chapter 1), (b) describe our efforts at over-expression, purification, and characterization of the catalytic domains of MMP7 (cdMMP7) and MMP16 (cdMMP16) (Chapters 2 and 3), (c) present our efforts at the preparation and initial spectroscopic characterization of Co(II)-substituted analogs of cdMMP7 and cdMMP16 (Chapters 2 and 3), (d) present inhibition data on cdMMP7 and cdMMP16 using zinc binding groups (ZBG) as potential scaffolds for future inhibitors (Chapter 3), and (e) summarize our data in the context of previous results and suggest future directions (Chapter 4). The work described in this dissertation integrates biochemical (kinetic assays, inhibition studies, limited computational methods), spectroscopic (CD, UV-Vis, 1H-NMR, fluorescence, and EXAFS), and analytical (MALDI-TOF mass spectrometry, isothermal calorimetry) methods to provide a detailed structural and mechanistic view of these MMPs.
    [Show full text]